Add Company
Join Now

Ganymed Pharmaceuticals Revenue and Competitors

License our Company Data API

Mainz,

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Ganymed Pharmaceuticals's estimated annual revenue is currently $1.9M per year.(i)
  • Ganymed Pharmaceuticals's estimated revenue per employee is $155,000

Employee Data

  • Ganymed Pharmaceuticals has 12 Employees.(i)
  • Ganymed Pharmaceuticals grew their employee count by 0% last year.

Ganymed Pharmaceuticals's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$81.4M37540%N/AN/A
#2
$16.9M10922%N/AN/A
#3
$156.1M120-70%$145MN/A
#4
$2.9M37-24%$150MN/A
#5
$1.3M170%$459.5MN/A
#6
$49.2M25415%$180.7MN/A
#7
$7M45-2%N/AN/A
#8
$256.3M8409%$168.5MN/A
#9
$4.2M27-7%N/AN/A
#10
$10.1M655%N/AN/A
Add Company

What Is Ganymed Pharmaceuticals?

GANYMED Pharmaceuticals AG is a biotechnology company based out of 12Freiligrathstraße, Mainz, Rhineland-Palatinate, Germany.

keywords:N/A

N/A

Total Funding

12

Number of Employees

$1.9M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Ganymed Pharmaceuticals News

2022-04-13 - Bispecific Antibody Market to Reach 810.4 Million, Globally, by ...

These pharma companies which are involved in the drug development have a strong ... Paktis Antibody Services GmBH; Ganymed Pharmaceuticals...

2022-04-06 - Bispecific Antibody Market Outlook: Post Covid-19 Scenario ...

... Post Covid-19 Scenario by 2028 | Oncomed Pharmaceuticals, Abbvie, ... Inc., Paktis Antibody Services GmBH, Ganymed Pharmaceuticals,...

2022-03-30 - AstraZeneca bets $25M on preclinical bispecific against hot ...

... the Big Pharma has landed worldwide rights to Harbour BioMed's (HBM's) ... euros ($459 million) to buy Ganymed Pharmaceuticals for its anti-CLDN18.2...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
N/A140%N/A
#2
$3.6M157%N/A
#3
$1.5M1713%N/A
#4
$2.9M190%N/A
#5
N/A21-22%N/A